Yanru Fei

157 Baojian Road
Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication.

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication.

Journal: International journal of molecular sciences
Published: November 21, 2025

The neddylation of the RNA-dependent RNA polymerase 3D of Coxsackievirus B3 promotes viral replication.

The neddylation of the RNA-dependent RNA polymerase 3D of Coxsackievirus B3 promotes viral replication.

Journal: Journal of virology
Published: October 31, 2025

Eukaryotic translation elongation factor 1 alpha 1 facilitates coxsackievirus B replication through interacting with PABP, viral protein 3 CD and viral RNA.

Eukaryotic translation elongation factor 1 alpha 1 facilitates coxsackievirus B replication through interacting with PABP, viral protein 3 CD and viral RNA.

Journal: Virulence
Published: October 18, 2025

N-Acetylcysteine Inhibits Coxsackievirus B3 Replication by Downregulating Eukaryotic Translation Elongation Factor 1 Alpha 1.

N-Acetylcysteine Inhibits Coxsackievirus B3 Replication by Downregulating Eukaryotic Translation Elongation Factor 1 Alpha 1.

Journal: Viruses
Published: July 26, 2024

TRIM56 restricts Coxsackievirus B infection by mediating the ubiquitination of viral RNA-dependent RNA polymerase 3D.

TRIM56 restricts Coxsackievirus B infection by mediating the ubiquitination of viral RNA-dependent RNA polymerase 3D.

Journal: PLoS pathogens
Published: April 08, 2024

Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1.

Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1.

Journal: Antiviral research
Published: February 25, 2023

Antiviral Activity of trans-Hexenoic Acid against Coxsackievirus B and Enterovirus A71.

Antiviral Activity of trans-Hexenoic Acid against Coxsackievirus B and Enterovirus A71.

Journal: Antimicrobial agents and chemotherapy
Published: February 14, 2023

Circular RNA circ_0076631 promotes coxsackievirus B3 infection through modulating viral translation by sponging miR-214-3p.

Circular RNA circ_0076631 promotes coxsackievirus B3 infection through modulating viral translation by sponging miR-214-3p.

Journal: Frontiers in microbiology
Published: June 22, 2022

Novel Antiviral Activity of Ethyl 3-Hydroxyhexanoate Against Coxsackievirus B Infection.

Novel Antiviral Activity of Ethyl 3-Hydroxyhexanoate Against Coxsackievirus B Infection.

Journal: Frontiers in microbiology
Published: February 14, 2022

Retrospective study of diagnosis and treatment of renal oncocytoma

Retrospective study of diagnosis and treatment of renal oncocytoma

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: August 18, 2019

MiR-146a down-regulates inflammatory response by targeting TLR3 and TRAF6 in Coxsackievirus B infection.

MiR-146a down-regulates inflammatory response by targeting TLR3 and TRAF6 in Coxsackievirus B infection.

Journal: RNA (New York, N.Y.)
Published: May 20, 2019

Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by Coxsackievirus B infection.

Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by Coxsackievirus B infection.

Journal: Antiviral research
Published: October 31, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026